我国合成生物产业创新发展路径与政策保障研究

Research on innovative development path and policy guarantee of China’s synthetic biology industry

        耿红军^1,3(南京理工大学 公共事务学院 南京 210094;深圳市科技创新战略研究中心 深圳 518052)
        王昶^2*(中南大学 商学院 长沙 410083)

         合成生物;产业发展;发展路径;政策保障

        synthetic biology;industrial development;development path;policy guarantee

        合成生物被誉为是继“DNA双螺旋结构”和“基因组技术”之后的第三次生命科学革命，是下一代生物制造与未来生物经济跨越式发展的核心驱动力，为全球制造业版图调整打开了机会窗口。如何抢先布局合成生物产业，抢占产业竞争制高点是全球科技强国、制造强国关注的核心议题。文章归纳了我国合成生物产业发展过程中存在的问题与部分典型国家的合成生物产业发展经验，以“融合转化”为主题，设计了推动合成生物产业有组织的融合创新及有价值的融合转化双重创新发展路径，并从完善合成生物产业发展机制、健全合成生物发展的政策支持体系、探索合成生物产品分类入市准入制度、健全合成生物监督管理体制机制等方面提出了政策保障措施。

        Synthetic biology is hailed as the third revolution in life sciences after the discovery of the DNA double helix structure and genomic technology, and is the core driving force for the leapfrog development of next-generation biomanufacturing and the future bioeconomy, opening up an opportunity window for the reshaping of the global manufacturing map. How to strategically position the synthesis biology industry and seize the strategic high ground in the industry is a core topic of interest for global science and technology powers and manufacturing powers. Based on the identification of problems in the development of China’s synthesis biology industry, this study draws on the experience of typical countries and takes integration and transformation as the theme to design dual innovation paths of organized innovation fusion and value-added transformation fusion for the synthesis biology industry, and proposes policy support measures from the perspectives of improving the development mechanism of the synthesis biology industry, strengthening the policy support system for the development of synthesis biology, exploring the classification entry and market access system for synthesis biology products, and improving the regulatory system and mechanism for synthesis biology.